{
    "2019-04-25": [
        [
            {
                "time": "",
                "original_text": "【中信建投医药】科创板系列研究之诺康达：专注药学制剂的研发外包企业",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "科创板",
                        "诺康达",
                        "药学制剂",
                        "研发外包"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:医保目录调整方案落地,创新药放量预期加速",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保目录",
                        "调整方案",
                        "创新药",
                        "放量预期",
                        "加速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}